Parkinson's disease (PD) is a progressive neurological ... As researchers seek effective treatments, stem cell therapies have emerged as a promising avenue. These therapies aim to replace lost ...

Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

To realize the promise of cell therapy for neurodegenerative disorders, S.Biomedics Co. Ltd. is looking to expand clinical ...

Researchers have successfully engineered bi-paternal mice, born from two male parents, that survived to adulthood using ...

The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers potential therapeutic ...

By crafting an artificial brain-like environment with microscopic nanopillars, researchers have successfully guided neurons to grow in structured networks. This innovation could revolutionize how scie ...

It's a case of so far, so good for BlueRock Therapeutics' first clinical trial of Parkinson's disease therapy bemdaneprocel ... in the quest to develop stem cell-based therapies for Parkinson ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Key cells in the brain, neurons, form networks by exchanging signals, enabling the brain to learn and adapt at incredible speed. Researchers at the Delft University of Technology in The Netherlands ...